Cell-based Assays: Technologies and Global Markets

An examination of how cell-based assays enable functional measures of target activation in a more relevant and informative setting when compared to biochemical assays Analysis of global market trends, with data from 2009, estimates for 2010, and projections of compound annual growth rates (CAGRs) through 2015 A breakdown of technology platforms at the forefront of cell-based assays, including flow cytometry, microscopy and image-based, laser capture microdissection and tissue microarrays, in situ hybridization, and molecular techniques Discussion of the market's competitive structure, mergers and acquisitions, and industry participants Comprehensive company profiles and patent analyses.

Additional Information

INTRODUCTION

STUDY GOALS AND OBJECTIVES

This BCC market research report, Cell-Based Assays: Technologies and Global Markets, provides a detailed overview and thorough analysis of the present and future global market for cell-based techniques. This report analyzes in detail the cell-based assays available and currently used and their markets. This report includes products in this market and detailed analyses of markets and competitive environments, cell assays markets in newly emerging regions, and instrumentation and robotics and their impact on the market. The report includes information about significant products and assays, key players, issues and trends, current market status of cell-based assays, strengths, weaknesses, opportunities, and threats facing various assays and developments already on the market, major issues involved in the research and development (R&D) of more effective cell-based approaches, for drug discovery, and absorption, distribution, metabolism, and excretion (ADME)/ toxicity assays in development and in use.

REASONS FOR DOING THE STUDY

Cell-Based assays have emerged as a more relevant alternative to biochemical assays involving the use of purified proteins. Witnessing the growth in demand for cell-Based assays, a number of cell culture and liquid-handling instruments available on the market now allow cell-based screening. The majority of compound screening programs performed by the biopharmaceutical industry rely on cell-based assays for functional measures of target activation. Label-free cellular assays are driving this paradigm forward, with their sensitivity, robustness, ease of use, and flexibility. These assays are now performed routinely throughout early drug discovery from target identification and validation to primary screening, lead identification, and lead optimization and into safety and toxicology. There is a need to understand the trends in this market, currently available assays, and latest developments for drug discovery.

SCOPE OF REPORT

The proposed report will give an update on Cell-Based Assays: Technologies and Global Markets. It will review global markets for cell-based assays and new developments and will forecast trends for use of these assays for drug discovery and safety and toxicology through 2015. Important assays, technologies and latest developments, market share by assay type, products on the market and market share by company, and statistical information for types of cancers prevalent worldwide, with special emphasis on the U.S. market. The report also includes current issues and trends affecting the industry and costs, and factors influencing demand will be discussed. The report covers products in development, new technologies, trends, alliances, and mergers. The report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints, and opportunities.

INTENDED AUDIENCE

This report is an exhaustive study on the worldwide cell-based assays market, giving crucial statistics and analysis on existing technologies, latest trends, market structure, market size, key drug segments, important trends in technology development, major opportunities, and market shares of key players and drugs. This report may prove crucial for the firms or investors seeking investments in the concerned sector. This report shows cell-based assays currently being used, new developments, spending trends, and revenue prospects for cell-based assays in pharma. The report provides market data for 2009 to 2015 and also covers commercial prospects for cell assays in drug research and ADME/toxicity assays.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this report. Secondary sources include books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, monitoring industry news, and developments and through access to paid databases. The base year of the report is 2009, with forecast data provided through 2015. Historical, base year and forecast data are provided for each market segment of this report. Growth rates are determined through a compilation of data, including past trends, future trends, demographics, incidence, mortality, products in R&D, and current product growth, etc.